Floatz logo

63 assets in Chemotherapy-Induced Toxicity

Therapeutic assets addressing Chemotherapy-Induced Toxicity, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Prednisolone
Chemotherapy-Induced Toxicity
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP2CCC (53)
Surufatinib
Chemotherapy-Induced Toxicity
Fujian Cancer HospitalP2CCC (53)
Herclon
Chemotherapy-Induced Toxicity
Incepta Pharmaceuticals LtdP1CC (47)
Blu-701
Chemotherapy-Induced Toxicity
Blueprint Medicines CorporationP1CC (43)
Osimertinib
Chemotherapy-Induced Toxicity
Blueprint Medicines CorporationP1CC (43)
Pebezertinib
Chemotherapy-Induced Toxicity
Blueprint Medicines CorporationP1CC (43)
Menthol
Chemotherapy-Induced Toxicity
Necmettin Erbakan UniversityN/AD (30)
ms-20
Chemotherapy-Induced Toxicity
National Taiwan University HospitalN/AD (30)
Romiplostim
Chemotherapy-Induced Toxicity
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Xihuang Pill
Chemotherapy-Induced Toxicity
Zhejiang Provincial People's HospitalN/AD (30)
Ganglioside-Monosialic Acid
Chemotherapy-Induced Toxicity
Sun Yat-sen UniversityP3NR ()
Showing 51 to 63 of 63 assets
PreviousPage 2 of 2Next